Opportunities in the oligonucleotide synthesis market include increased demand for personalized therapies, growth in contract synthesis services, expanding capabilities in large-scale oligonucleotide ...
The United States continues to lead in biopharmaceutical R&D, peptide drug development, and precision medicine applications.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback